Astria Therapeutics, Inc.ATXSNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-111.56M
↓ 142% below average
Average (9y)
$-46.15M
Historical baseline
Range
High:$-25.65M
Low:$-111.56M
CAGR
+15.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-111.56M | -34.4% |
| 2023 | $-83.03M | -55.2% |
| 2022 | $-53.50M | -76.2% |
| 2021 | $-30.36M | +18.8% |
| 2020 | $-37.41M | -38.2% |
| 2019 | $-27.06M | -5.5% |
| 2018 | $-25.65M | +3.6% |
| 2017 | $-26.60M | +23.6% |
| 2016 | $-34.83M | -10.7% |
| 2015 | $-31.46M | - |